Skip to main content

Pulmonx Corp

LUNG
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001127537

In the last 90 days, Pulmonx Corp insiders filed 0 open-market purchases and 4 sales; 107 institutions reported holding it in 13F filings for Q2 2026, worth $34.1M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Pulmonx Corp changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of LUNG: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders107104−3
Shares35.3M34.9M−442.3K (−1.3%)
Value$520.2M$581.4M+$61.2M (+11.8%)

New holders (17)

Institutions that held Pulmonx Corp at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to LUNG in Q3 2022
InstitutionSharesValue% of portfolio
PFM Health Sciences, LP199,703$3.33M0.13%
Russell Investments Group, Ltd.96,250$1.60M0.00%
Twinbeech Capital LP50,174$836.0K0.02%
State of Wisconsin Investment Board45,197$753.0K0.00%
Calamos Advisors LLC41,111$685.0K0.00%
Prelude Capital Management, LLC21,704$362.0K0.02%
Group One Trading, L.P.18,808$313.0K0.01%
CenterBook Partners LP18,654$311.0K0.06%
Mirae Asset Global Investments Co., Ltd.14,391$240.0K0.00%
Walleye Trading LLC10,868$181.0K0.01%
Amundi2,562$44.0K0.00%
Ensign Peak Advisors, Inc1,780$30.0K0.00%
MCF Advisors LLC575$10.0K0.00%
Signaturefd, LLC31$1.00K0.00%
Bellevue Asset Management, LLC64$1.00K0.00%
Nisa Investment Advisors, LLC35$00.00%
Ellevest, Inc.1$00.00%

Sold out (20)

Institutions that held Pulmonx Corp at the end of Q2 2022 and filed for Q3 2022 without it.